These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome. Cellier C; Patey N; Fromont-Hankard G; Cervoni JP; Leborgne M; Chaussade S; Barbier JP; Brousse N Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1197-203. PubMed ID: 9471026 [TBL] [Abstract][Full Text] [Related]
3. Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease. Vainer B; Nielsen OH; Horn T Am J Surg Pathol; 2000 Aug; 24(8):1115-24. PubMed ID: 10935652 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Griga T; May B; Pfisterer O; Müller KM; Brasch F Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933 [TBL] [Abstract][Full Text] [Related]
5. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease. Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases. Martinesi M; Treves C; Bonanomi AG; Milla M; Bagnoli S; Zuegel U; Steinmeyer A; Stio M Clin Immunol; 2010 Jul; 136(1):51-60. PubMed ID: 20399147 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637 [TBL] [Abstract][Full Text] [Related]
8. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. Van Assche G; Rutgeerts P Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604 [TBL] [Abstract][Full Text] [Related]
9. Sialomucin ligands for selectins: a new family of cell adhesion molecules. Lasky LA Princess Takamatsu Symp; 1994; 24():81-90. PubMed ID: 8983065 [TBL] [Abstract][Full Text] [Related]
10. [Adhesion molecules: their role in physiopathology and treatment of inflammatory bowel disease]. Panés J Gastroenterol Hepatol; 1999 Dec; 22(10):514-24. PubMed ID: 10650667 [No Abstract] [Full Text] [Related]
11. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Kilic B; Kruse M; Stahlmann R Toxicology; 2006 Jan; 218(1):30-8. PubMed ID: 16297520 [TBL] [Abstract][Full Text] [Related]
12. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283 [TBL] [Abstract][Full Text] [Related]
19. Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa. Coll-Vinent B; Cebrián M; Cid MC; Font C; Esparza J; Juan M; Yagüe J; Urbano-Márquez A; Grau JM Arthritis Rheum; 1998 Mar; 41(3):435-44. PubMed ID: 9506571 [TBL] [Abstract][Full Text] [Related]
20. [The effects of anti-inflammatory on activation of nuclear factor-kappaB and expression of cell adhesion molecules in patients with ulcerative colitis]. Chen Y; Gan H; Ouyang Q; Xu D; Pan Y; A Z Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):732-6. PubMed ID: 15553846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]